A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells

Experimental Cell Research

Volumn 238, Issue 2, 1998, Pages 407-414

  Herrera, Roman ^a   Hubbell, Susan ^a   Decker, Stuart ^a   Petruzzelli, Lilli ^b,c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PRIORITY JOURNAL;

EID: 0031825731     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3847     Document Type: Article

References (65)

1. Shivdasani R. A., Orkin S. H. The transcriptional control of hematopoiesis. Blood. 87:1996;4025-4039.
2. Metcalf D. The molecular control of cell division, differentiation commitment and maturation of hematopoietic cells. Nature. 339:1989;27-30.
3. Alitalo R. Induced differentiation of K562 leukemia cells: A model for studies of gene expression in early megakaryoblasts. Leuk. Res. 14:1990;501-514.
4. Long M. W., Heffner C. H., Williams J. L., Peters C., Prochownik E. V. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J. Clin. Invest. 85:1990;1072-1084.
5. Colamonici O. R., Trepel J. B., Neckers L. M. Phorbol ester enhances deoxynucleoside incorporation while inhibiting proliferation of K-562 cells. Cytometry. 6:1985;591-596.
6. Tetteroo P. A. T., Massaro F., Mulder A., Schreuder-van Gelder R., Kr. von dem Borne A. E. G. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 8:1984;197-206.
7. Fukuda M. Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells. Cancer Res. 41:1981;4621-4628.
8. Butler T. M., Ziemiecki A., Friis R. R. Megakaryocytic differentiation of K562 cells is associated with changes in the cytoskeletal organization and the pattern of chromatographically distinct forms of phosphotyrosyl-specific protein phosphatases. Cancer Res. 50:1990;6323-6329.
9. Hocevar B. A., Morrow D. M., Tykocinski M. L., Fields A. P. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J. Cell Sci. 101:1992;671-679.
10. Datta N. S., Williams J. L., Caldwell J., Curry A. M., Ashcraft E. K., Long M. W. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol. Biol. Cell. 7:1996;209-223.
11. Garcia P., Cales C. Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C. Oncogene. 13:1996;695-703.
12. Zhang Y., Wang Z., Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J. Biol. Chem. 271:1995;4266-4272.
13. Murray N. R., Baumgardner G. P., Burns D. J., Fields A. P. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. J. Biol. Chem. 268:1993;15847-15853.
14. Alitalo R., Partanen J., Pertovaara L., Holtta E., Sistonen L., Andersson L., Alitalo K. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells. Blood. 75:1990;1974-1982.
15. Cheng T., Wang Y., Dai W. Transcription factor egr-1 is involved in phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J. Biol. Chem. 269:1994;30848-30853.
16. Namciu S., Lieberman M. A., Stavnezer E. Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation. Oncogene. 9:1994;1407-1416.
17. Colamonici O. R., Trepel J. B., Vidal C. A., Neckers L. M. Phorbol ester induces c-sis gene transcription in stem cell line K-562. Mol. Cell. Biol. 6:1986;1847-1850.
18. WAF1/CIP1. Oncogene. 1996;1557-1564.
19. 21. Exp. Cell Res. 202:1992;28-35.
20. 21IIb3. J. Biol. Chem. 267:1992;20233-20238.
21. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
22. Crews C. M., Erikson R. L. Extracellular signals and reversible protein phosphorylation: What to Mek of it all. Cell. 74:1993;215-217.
23. Blenis J. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc. Natl. Acad. Sci. USA. 90:1993;5889-5892.
24. Faure M., Voyno-Yasenetskaya T. A., Bourne H. R. cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269:1994;7851-7854.
25. Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
26. Okazaki K., Sagata N. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14:1995;5048-5059.
27. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
28. Pumiglia K. M., Decker S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA. 94:1997;448-452.
29. Pang L., Sawada T., Decker S. J., Saltiel A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
30. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
31. Sale E. M., Atkinson P. G. P., Sale G. J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 14:1995;674-684.
32. Alberola-Ila J., Forbush K. A., Seger R., Krebs E. G., Perlmutter R. M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:1995;620-623.
33. Crompton T., Gilmour K. C., Owen M. J. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell. 86:1996;243-251.
34. Brunner D., Oellers N., Szabad J., Biggs W. H. III, Zipursky S. L., Haten E. A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways. Cell. 76:1994;875-888.
35. Rouyez M. C., Boucheron C., Gisselbrecht S., Dusanter-Fourt I., Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17:1997;4991-5000.
36. Racke F. K., Lewandowska K., Goueli S., Goldfarb A. N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J. Biol. Chem. 272:1997;28866-28870.
37. Whalen A. M., Galasinski S. C., Shapiro P. S., Nahreini T. S., Ahn N. G. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17:1997;1947-1958.
38. Stacker S. A., Springer T. A. Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J. Immunol. 146:1991;648-655.
39. Dean P. N. Techniques in Cell Cycle Research. 1987;Humana Press, Clifton. p. 207-253.
40. cas. J. Biol. Chem. 271:1996;7796-7801.
41. Dudley D. T., Pang L., Decker S. J., Bridges A. J., Saltiel A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
42. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinasein vitroin vivo. J. Biol. Chem. 270:1995;27489-27494.
43. Rao V. N., Reddy E. S. elk-1 proteins interact with MAP kinases. Oncogene. 9:1997;1855-1860.
44. Miyasaka T., Chao M. V., Sherline P., Saltiel A. R. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2. J. Biol. Chem. 265:1990;4730-4735.
45. Chen Q., Kinch M. S., Lin T. H., Burridge K., Juliano R. L. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 269:1994;26602-26605.
46. erk-1erk-2. J. Biol. Chem. 270:1995;269-273.
47. Zhu X., Assoian R. K. Integrin-dependent activation of MAP kinase: A link to shape-dependent cell proliferation. Mol. Biol. Cell. 6:1995;273-282.
48. 2. J. Biol. Chem. 271:1996;14814-14818.
49. Chen Q., Lin T. H., Der C. J., Juliano R. L. Integrin-mediated activation of mitogen-activated protein (MAP) or extracellular signal-related kinase kinase (MEK) and kinase is independent of Ras. J. Biol. Chem. 271:1996;18122-18127.
50. Schlaepfer D. D., Hanks S. K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791.
51. Campbell M. L., Lu D., Guo J. Q., Arlinghaus R. B. Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells. Cell Growth Differ. 4:1993;581-588.
52. Yoshino T., Sakaguchi M., Masuda T., Kawakita M., Takatsuki K. Two regulation points for differentiation in the cell cycle of human megakaryocytes. Br. J. Haematol. 92:1996;780-787.
53. 01. Cell Growth Differ. 7:1996;75-81.
54. Smarda J., Lipsick J. S. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene. 1993;237-245.
55. Yen A., Varvayanis S., Platko J. D. 12-O. Cancer Res. 53:1993;3085-3091.
56. Murate T., Hotta T., Tsushita K., Suzuki M., Yoshida T., Saga S., Saito H., Yoshida S. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-01. Blood. 78:1991;3168-3177.
57. 1. Exp. Cell. Res. 208:1993;35-43.
58. Hong Y., Martin J. F., Vainchenker W., Erusalimsky J. D. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Blood. 87:1996;123-131.
59. VanRenterghem B., Browning M. C., Maller J. L. Regulation of mitogen-activated protein kinase activation by protein kinases A and C in a cell-free system. J. Biol. Chem. 269:1994;24666-24672.
60. Buscher D., Hipskind R. A., Krautwald S., Reimann T., Baccarini M. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 15:1995;466-475.
61. Pendergast A. M., Quilliam L. A., Cripe L. D., Bassing C. H., Dai Z., Li N., Batzer A., Rabun K. M., Der C. J., Schlessinger J., Gishizky M. L. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 75:1993;175-185.
62. Cortez D., Kadlec L., Pendergast A. M. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15:1995;5531-5541.
63. Raitano A. B., Halpern J. R., Hambuch T. M., Sawyers C. L. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA. 92:1995;11746-11750.
64. Franklin C. C., Kraft A. S. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Oncogene. 11:1995;2365-2374.
65. Kang C. D., Lee B. K., Kim K. W., Kim C. M., Kim S. H., Chung B. S. Signaling mechanism of PMA-induced differentiation of K562 cells. Biochem. Biophys. Res. Commun. 221:1996;95-100.